Clinical trial
The Study of Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Population Of Chinese Patient (SAFAR-China)
NCT03154203 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study of Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Population Of Chinese Patient (SAFAR-China)
- Lead sponsor
- Shanghai 10th People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2017
- Completion date
- June 30, 2021
- Enrollment
- 3,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood pressure, cardiovascular events, cardiovascular mortality, cardiovascular risk factor, overall mortality, target organ damage